Format

Send to

Choose Destination
Lancet Respir Med. 2017 Jan;5(1):5-6. doi: 10.1016/S2213-2600(16)30369-1. Epub 2016 Nov 4.

Targeted therapy outcomes in RET-rearranged lung cancers: drug or driver?

Author information

1
Thoracic Oncology Service and Developmental Therapeutics Clinic, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: drilona@mskcc.org.
PMID:
27825615
DOI:
10.1016/S2213-2600(16)30369-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center